Advertisement
Australia markets close in 4 hours 7 minutes
  • ALL ORDS

    7,935.00
    -2.90 (-0.04%)
     
  • ASX 200

    7,681.70
    -1.80 (-0.02%)
     
  • AUD/USD

    0.6525
    +0.0036 (+0.56%)
     
  • OIL

    83.29
    -0.07 (-0.08%)
     
  • GOLD

    2,330.70
    -11.40 (-0.49%)
     
  • Bitcoin AUD

    102,258.50
    -319.80 (-0.31%)
     
  • CMC Crypto 200

    1,439.11
    +24.35 (+1.72%)
     
  • AUD/EUR

    0.6090
    +0.0033 (+0.55%)
     
  • AUD/NZD

    1.0978
    +0.0048 (+0.44%)
     
  • NZX 50

    11,857.23
    +53.95 (+0.46%)
     
  • NASDAQ

    17,471.47
    +260.59 (+1.51%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • Dow Jones

    38,503.69
    +263.71 (+0.69%)
     
  • DAX

    18,137.65
    +276.85 (+1.55%)
     
  • Hang Seng

    17,025.08
    +196.15 (+1.17%)
     
  • NIKKEI 225

    38,230.54
    +678.38 (+1.81%)
     

Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and Beyond

Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and Beyond

On top of those pluses, these three companies all have a history of offering above-average dividends, making them solid long-term value bargains. Takeda is a Japanese biopharmaceutical company that focuses on gastroenterology, oncology, neuroscience, and rare diseases. The company's stock is up more than 9% this year, currently trading at just shy of $15.